Vicente, J.; Peñaranda Figueredo, F.A.; Mantovani, S.; Papademetrio, D.L.; Nemirovsky, S.I.; Barquero, A.A.; Shayo, C.; Bueno, C.A.
Imiquimod, a Promising Broad-Spectrum Antiviral, Prevents SARS-CoV-2 and Canine Coronavirus Multiplication Through the MAPK/ERK Signaling Pathway. Viruses 2025, 17, 801.
https://doi.org/10.3390/v17060801
AMA Style
Vicente J, Peñaranda Figueredo FA, Mantovani S, Papademetrio DL, Nemirovsky SI, Barquero AA, Shayo C, Bueno CA.
Imiquimod, a Promising Broad-Spectrum Antiviral, Prevents SARS-CoV-2 and Canine Coronavirus Multiplication Through the MAPK/ERK Signaling Pathway. Viruses. 2025; 17(6):801.
https://doi.org/10.3390/v17060801
Chicago/Turabian Style
Vicente, Josefina, Freddy Armando Peñaranda Figueredo, Stefania Mantovani, Daniela Laura Papademetrio, Sergio Ivan Nemirovsky, Andrea Alejandra Barquero, Carina Shayo, and Carlos Alberto Bueno.
2025. "Imiquimod, a Promising Broad-Spectrum Antiviral, Prevents SARS-CoV-2 and Canine Coronavirus Multiplication Through the MAPK/ERK Signaling Pathway" Viruses 17, no. 6: 801.
https://doi.org/10.3390/v17060801
APA Style
Vicente, J., Peñaranda Figueredo, F. A., Mantovani, S., Papademetrio, D. L., Nemirovsky, S. I., Barquero, A. A., Shayo, C., & Bueno, C. A.
(2025). Imiquimod, a Promising Broad-Spectrum Antiviral, Prevents SARS-CoV-2 and Canine Coronavirus Multiplication Through the MAPK/ERK Signaling Pathway. Viruses, 17(6), 801.
https://doi.org/10.3390/v17060801
